Company Information

  

Address: 333 LAKESIDE DR  
City: FOSTER CITY 
State: CA 
Zip Code: 94404 
Telephone: 650-574-3000 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Gilead Sciences, Inc. (Gilead, we, our or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. We have operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead's primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. We seek to add to our existing portfolio of products through our internal discovery and clinical development programs, product acquisition, in-licensing and strategic collaborations. 2018 Highlights 2018 was marked by operational excellence and transition as we positioned ourselves for the future growth of our business.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/20197.040.6309.23
12/20184.170.57015.00
09/20181.250.57061.77
06/20181.710.57041.43
03/20182.660.57028.34
12/20173.540.52020.24
09/20178.790.5209.22
06/20179.210.5207.69

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2018 Leverage 2018
Net Inc/Comm Equity2.39Total Liab/Total Assets0.66
Net Inc/Total Assets0.09Total Liab/Inv Cap0.84
Net Inc/Inv Cap0.11Total Liab/Comm Equity18.52
Pretax Inc/Net Sales0.35Interest Coverage Ratio8.24
Net Inc/Net Sales0.25Curr Debt/Equity0.13
Cash Flow/Net Sales0.38LTD/Equity1.15
SG&A/NetSales0.18Total Debt/Equity1.28
Asset Utilization   Liquidity  
Net Receivables Turnover6.17Quick Ratio3.30
Inventory Turnover6.01Current Ratio3.38
Inventory Day Sales0.02Net Rec/Curr Assets0.09
Net Sales/Work Cap0.88Inv/Curr Assets0.02
Net Sales/PP&E5.52  

Income Statement (Millions)

  3/31/2019 12/31/2018 9/30/2018 6/30/2018
Total Revenues(Net Sales) 5,281.00 5,795.00 5,596.00 5,648.00
Cost of Goods Sold 957.00 1,570.00 1,086.00 1,196.00
Selling & Admin Exps 1,030.00 1,131.00 948.00 980.00
Operating Income 2,237.00 1,144.00 2,623.00 2,280.00
Interest Exp 254.00 257.00 264.00 266.00
Pretax Income 2,350.00 1,016.00 2,664.00 2,086.00
Other Income 367.00 129.00 305.00 72.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 1,975.00 3.00 2,097.00 1,817.00

Balance Sheet (Millions)

Assets 3/31/2019 12/31/2018 9/30/2018 6/30/2018
Cash & Short Term Investments 27,904.00 30,089.00 28,466.00 25,917.00
Receivables - Total 3,283.00 3,327.00 3,465.00 3,541.00
Inventories - Total 898.00 814.00 816.00 859.00
Total Current Assets 34,024.00 35,836.00 34,918.00 32,728.00
Net Property, Plant & Equipment 4,116.00 4,006.00 3,791.00 3,659.00
Total Assets 62,837.00 63,675.00 64,305.00 65,355.00
Liabilities        
Accounts Payable 6,899.00 7,857.00 7,369.00 7,914.00
Debt in Current Liabilities 2,498.00 2,748.00 2,747.00 2,998.00
Total Current Liabilities 9,397.00 10,605.00 10,116.00 10,912.00
Long-Term Debt 24,080.00 24,574.00 24,570.00 26,062.00
Total Liabilities 40,886.00 42,288.00 41,444.00 43,683.00
Stockholder's Equity        
Minority Interest 140.00 147.00 146.00 62.00
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 1.00 1.00 1.00 1.00
Retained Earnings 19,326.00 19,024.00 20,706.00 19,825.00
Treasury Stock NA NA NA NA
Total Stockholders' Equity 21,951.00 21,387.00 22,861.00 21,672.00
Total Liabilities and Stockholders' Equity 62,837.00 63,675.00 64,305.00 65,355.00

Cash Flow Summary (Millions)

Categories 3/31/2019 12/31/2018 9/30/2018 6/30/2018
Net Cash Provided by Operating Activities 1,444.00 2,345.00 2,212.00 1,573.00
Net Cash Provided by Investing Activities -111.00 2,735.00 2,025.00 5,241.00
Net Cash Provided by Financing Activities -2,366.00 -1,670.00 -2,901.00 -1,152.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201424,890.0012,101.007.35
12/201532,639.0018,108.0011.91
12/201630,390.0013,501.009.94
12/201726,107.004,628.003.54
12/201822,127.005,455.004.17
Growth Rates-2.90-18.06-13.21

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1916011,021,38780.33




Report Date : 7/15/2019

Powered By Edgar Online © 2019EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.